-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下：鉴于TWLO近期的增长和利润率的显著提升，我们将目标股价上调54美元至211美元，市盈率30倍（基于2027年预期每股收益），高于TWLO三年平均市盈率（约22倍）。我们将2026年预期每股收益上调0.51美元至5.92美元，并将2027年预期每股收益上调0.65美元至7.02美元。TWLO 2026年的有机销售增长预期从约8.5%大幅跃升至10%，我们认为第一季度的出色表现（+16%）有望持续全年，从而带来上涨空间。人工智能原生应用需求的增长催生了更多多产品客户（同比增长29%，高于第四季度的26%），随着这些客户的快速扩张，我们预计TWLO将拥有长期的增长前景。盈利能力的提升仍然是关键的驱动因素，第一季度的营业利润率表现亮眼，无论是按非GAAP准则（同比增长160个基点）还是按GAAP准则（同比增长600个基点）计算，均表现出色，而SBC（服务业务成本）则从上季度的11%降至10%。我们认为，TWLO受益于日益增长的智能体人工智能活动所带来的潜在收益，远远超过人工智能“感知编码”带来的竞争风险，早期结果也清晰地表明，TWLO更倾向于利用第三方来构建通信基础设施。
Related Articles
Australia
Novartis Gains Canada Nod for Fabhalta in Rare Kidney Disease
Novartis (NVS) said Health Canada has approved Fabhalta for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.C3G is a rare, long-term kidney disease caused by an overactive immune pathway. This leads to a buildup of protein in the kidneys, causing inflammation, damage and, over time, loss of kidney function.The approval was backed by Phase III data showing a statistically significant reduction in proteinuria at six months, with sustained benefits through one year.Fabhalta (iptacopan) is an oral drug that blocks a key part of the immune system (Factor B), helping reduce the harmful activity that drives C3G and protects the kidneys.Price: $146.84, Change: $-1.01, Percent Change: -0.68%
$NVS
Research
Research Alert: CFRA Maintains Hold Rating On Shares Of Commvault Systems Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our target price to $106, from $101, on a forward P/E of 21x our FY 27 EPS estimate of $5.05, below its three-year average. We increase our FY 27 EPS projection to $5.05 from $4.80, and start our FY 28 EPS forecast at $5.90. CVLT reported solid Q4 results, above consensus views, with total revenue rising 13% Y/Y to $312M, fueled by subscription revenue growth of 20% to $208M and strong SaaS revenue contribution of $93M (+43% Y/Y). SaaS ARR rose 42% to $400M, while subscription ARR hit $989M, up 27% Y/Y, with net new ARR of $53M marking the strongest quarterly performance of FY26. Results reflect momentum in the business as CVLT benefits from data security challenges from AI use. We anticipate long-term tailwinds, but note greater macro and demand uncertainty in FY 27. We highlight impressive FCF generation (record $132M) and continued margin expansion expected in the new fiscal year.
$CVLT
Commodities
US Soybean Crush Rose in March, Stocks Tightened, USDA Says
The US Department of Agriculture on Friday reported that soybean crush for March rose above February and year-ago totals, but stocks dropped.In its monthly Oilseed Crushings, Production, Consumption and Stocks Report, the USDA pegged soybeans crushed for crude oil at 6.82 million metric tons, or 227 mb, in March 2026, compared with 6.43 million mt, or 214 mb, in February 2026, and 6.20 million mt, or 207 mb, in March 2025.The amount of crude oil produced from crushed soybeans was 2.64 billion pounds, up 6% from February 2026 and up 7% from March 2025.Production of soybean oil, once refined, totaled 2 billion pounds in March 2026, up 14% from February 2026 and 7% from March 2025.Iowa facilities crushed a total of 1.5 million mt, followed by facilities in the North and Eastern US, totaling 1.3 million mt.Soybean-based crude oil stocks, as of March 31, 2026, totaled 2 billion pounds, slightly below 2.1 billion in February.Corn oil crushed to produce crude oil totaled 139 million pounds in March, above 132.7 million pounds in February.